missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ Human SFT2D2 (aa 1-33) Control Fragment Recombinant Protein

Catalog No. RP99840
Change view
Click to view available options
Quantity:
100 μL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
RP99840 100 μL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. RP99840 Supplier Invitrogen™ Supplier No. RP99840
Only null left

Recombinant Protein

Highest antigen sequence indentity to the following orthologs: Mouse (97%), Rat (97%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-59914 (PA5-59914. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.

May be involved in fusion of retrograde transport vesicles derived from an endocytic compartment with the Golgi complex.

Specifications

Accession Number O95562
Concentration ≥5.0 mg/mL
For Use With (Application) Blocking Assay, Control
Formulation 1 M urea, PBS with no preservative; pH 7.4
Gene ID (Entrez) 375035
Name Human SFT2D2 (aa 1-33) Control Fragment
Quantity 100 μL
Regulatory Status RUO
Gene Alias 2010005O13Rik; AI506168; AW561909; cI-45; dJ747L4.C1.2; RGD1310623; SFT2 domain containing 2; SFT2 domain-containing protein 2; SFT2D2; sft2d2 {ECO:0000250; UniProtKB:O95562}; UNQ512; UNQ512/PRO1027; Vesicle transport protein SFT2B
Common Name SFT2D2
Gene Symbol SFT2D2
Conjugate Unconjugated
Species Human
Recombinant Recombinant
Protein Tag His-ABP-tag
Sequence MDKLKKVLSGQDTEDRSGLSEVVEASSLSWSTR
Content And Storage -20°C, Avoid Freeze/Thaw Cycles
Expression System E. coli
Form Liquid
Purity or Quality Grade >80% by SDS-PAGE and Coomassie blue staining
Show More Show Less